Literature DB >> 19775659

IMRT and molecular biological approaches in radiotherapy for prostate cancer.

Robert G Bristow1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19775659     DOI： 10.1016/S0959-8049(09)70077-2

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  1 in total

1.  Plasma osteopontin as a biomarker of prostate cancer aggression: relationship to risk category and treatment response.

Authors:  J W Thoms; A Dal Pra; P H Anborgh; E Christensen; N Fleshner; C Menard; K Chadwick; M Milosevic; C Catton; M Pintilie; A F Chambers; R G Bristow
Journal:  Br J Cancer       Date:  2012-08-07       Impact factor: 7.640
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.